logo

Search studies

13 studies found

OncoTrack study
ELU-4-24D114-1

OncoTrack attempts to address the core problems of drug-based cancer therapies: the low response rate of patients to their therapies, as well as its inevitable consequence, the low approval rates of oncology drugs. Only about 10% of cancer drug candidates entering clinical development are granted marketing authorization. Our program is based on two seminal developments: significant progress in our ability to analyze the molecular characteristics of individual tumors and patients (predominantl...

  • Types: Clinical Trial Ncit:c71104

PSD-COVID19-OMICS
e6f87415-04f3-11ec-96d0-d0577bab103e

PSD COVID19 OMICS

  • Types: Psd Covid19 Omics

UDUS-MiRCOVID
e6f87413-04f3-11ec-8af3-d0577bab103e

MiRCOVID participants` samples and data for COVIRNA

  • Types: Mircovid Participants` Samples And Data For Covirna

ULEI-PROVID-CAPNETZ-2
e6f87419-04f3-11ec-a27b-d0577bab103e

PROVID cohort of hospitalized COVID-19 patients

  • Types: Provid Cohort Of Hospitalized Covid-19 Patients

ULEI-PROVID-PROGRESS-1
e6f87417-04f3-11ec-a738-d0577bab103e

PROVID cohort of hospitalized COVID-19 patients

  • Types: Provid Cohort Of Hospitalized Covid-19 Patients